北京大学基础医学院

院长论坛

报告题目：新药研发与药物代谢酶系和药代动力学模型

（Drug/Xenobiotic Metabolic Enzymes and PBPK Modeling

in Drug Discovery）

报 告 人：Dr. Chuang Lu，Department of DMPK at Millennium Pharmaceuticals, Inc., The TakedaOncology Cambridge, MA. USA

时   间： 2014年5月9日 (星期五)  上午8: 30

地   点： 基础医学院药理学系会议室 (生理楼二楼中厅)

主 持 人：章国良 教授

报告人简介：

Dr. Chuang Lu is a Scientific Fellow in DMPK at Millennium, The Takeda Oncology Company. He received his B.S. degree in Chemistry from the Beijing University in 1982 and his Ph.D. in the Environmental Chemistry from the American University of Washington, DC in 1992. He did his postdoctoral training at the USDA from 1992 to 1996 with emphasis on the mutagenicity of pesticides and monoclonal antibody techniques.  He then worked for the In Vitro Technologies, Inc. as a Principal Scientist and focused his research on the hepatocyte cryopreservation and application of primary cells in drug metabolism.  Dr. Lu joined Millennium in 2000 and his current research interests include drug metabolizing enzymes, drug-drug interaction, and in vitro – in vivo correlation including PBPK modeling.

欢迎师生参加！